Replies to post #26579 on Marker Therapeutics Inc (MRKR)

[Inoviorulez]

"—Company to report update from Phase 1/2 clinical trial in pancreatic cancer in Q3 2019—"

https://www.markertherapeutics.com/2019/05/marker-therapeutics-reports-first-quarter-2019-operating-and-financial-results/